Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SPIN4 antisense RNA 1 is a long non-coding RNA transcribed antisense to the SPIN4 locus and annotated in genome databases. There is currently no published data on its protein product, direct biological functions, disease relevance, or drug interactions. The gene is catalogued in genome annotation resources (GeneCards, NCBI Gene)[7][10] but lacks functional characterization in scientific literature. While some antisense lncRNAs have regulatory functions or disease associations[8], there is no evidence for SPIN4-AS1 itself being considered a therapeutic target, biomarker, or having clinical significance. Caution is advised to avoid confusion with similarly named but functionally characterized antisense RNAs like SPINT1-AS1[2][6]. There is a recurring confusion with "SPINT1-AS1," which is a well-characterized long non-coding RNA associated with cancer prognosis and progression[2][6]. SPIN4-AS1 does not share this biological function or clinical relevance based on current data.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SPIN4 antisense RNA 1 (SPIN4-AS1).